The Children’s Diabetes Program at Monroe Carell Jr. Children’s Hospital at Vanderbilt recently unveiled its latest tool in helping to prevent diabetic retinopathy, the leading cause of acquired blindness in the United States.
Last month, hundreds of patients living with diabetes and their family members joined the staff of the Vanderbilt Children’s Diabetes Program for the 14th annual Diabetes Family Day at the Vanderbilt Student Life Center.
Service and research achievement was recognized recently during the annual Diabetes Day sponsored by the Vanderbilt Diabetes Research and Training Center and the Vanderbilt Center for Diabetes Translation Research.
Microtubules — cellular “highways” that deliver cargo to the cell membrane for secretion — have a surprising role in pancreatic beta cells. Instead of facilitating glucose-stimulated insulin secretion, they limit it, a team of Vanderbilt investigators reported recently in Developmental Cell.
The growth factor FGF1 induces the growth of new insulin-producing beta cells and may help treat type 2 diabetes.